Mitochondrial dysfunction and oxidative stress mediate the physiological impairment












































There is a growing interest in the role of macro-
autophagy, herein simply termed autophagy, in both 
normal homeostasis and in a variety of pathological 
conditions [1, 2]. This interest has been sparked in 
part by observations suggesting that in lower 
organisms, autophagy is an important determinant of 
lifespan [3]. For instance, in C elegans, the life 
extending effects of mutation in the daf-2 pathway 
requires an intact autophagy program [4, 5].  Similar- 
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‐/‐cells  also  exhibit  evidence  for  increased  steady  state  levels  of  reactive  oxygen  species.  The  observed
mitochondrial  dysfunction  and  oxidative  stress  is  also  evident  in  a  mouse  model  where  Atg7  is  deleted  within  the
pancreatic β cell. In this model, the simple administration of an antioxidant can significantly ameliorate the physiological







ly, in the worm, the increase in lifespan seen with 
dietary restriction is not evident when autophagy is 
impaired [6]. Consistent with these observations, 
genetic manipulations that can increase autophagy in 
Drosophila result in flies with an extended lifespan 
and an increase in overall stress resistance [7].  
 
Less is known regarding the role of autophagy in 
mammalian systems. Prior to the establishment of 
the molecular and biochemical basis for autophagy, 
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characterized by the accumulation of damaged 
cellular components. In addition, consistent with a 
defect in autophagy, it was also evident that animal 
tissues exhibited an age-dependent decline in the 
turnover rates of long lived proteins [8]. These and 
other studies have suggested that autophagic flux 
declines with age and that the magnitude and timing 
of this decline is in general concordance with the 
age-dependent accumulation of damaged proteins 
and organelles seen within aging tissues. Recent 
genetic mouse models have strengthened this 
association. While complete knockouts of essential 
autophagy genes appear to be lethal in the neonatal 
stage, various conditional knockout models have 
been recently described. Among these recent results 
are the description of tissue specific deletions of 
essential autophagy genes in liver, brain, pancreas 
and heart [9-14]. While significant differences exist 
in these various model systems, most were 
characterized by the rapid appearance of various 
pathologies and physiological impairments that can 
also be observed as a consequence of normal aging.  
 
Relatively little is known about the downstream 
mediators of the often profound physiological 
alterations observed following the disruption of 
autophagic flux. Most likely there is no single 
pathway across all tissues and organs, and even 
within a single tissue type, multiple mediators may 
exist. For instance, while the accumulation of 
misfolded and aggregated proteins normally cleared 
in part by autophagy are likely to play a prominent 
role in models of neurodegeneration, in other tissues, 
the role of accumulation of damaged protein 
aggregates is less clear. This tissue specificity was 
reinforced by recent observations demonstrating that 
deletion of p62, a ubiquitin and LC3/Atg8 binding 
protein, rescues the pathological changes observed 
in autophagy deficient liver but does not appear to 
alter the phenotypic changes seen following deletion 
of Atg7 in the brain [15].  
 
One important function of autophagy is the turnover 
of organelles including mitochondria. While several 
reports have described the structural changes in 
mitochondrial appearance evident in electron 
micrographs taken of autophagy deficient 
mammalian tissues [9, 12-14] , the functional 
alterations, if any, of these mitochondria have not 
been reported. Here, using a variety of cellular and 
in vivo models of Atg7 deficiency, we have assessed 
the magnitude of mitochondrial dysfunction and the 
contribution of the corresponding oxidative stress in 
mediating the physiological impairment observed 




Mitochondrial dysfunction in Atg7 deficient 
skeletal muscle 
 
In an effort to more fully characterize the role of 
autophagy in the maintenance of normal 
mitochondrial function, we created a conditional 
knockout model in which Atg7, an essential gene 
required for autophagosome formation, was deleted 
from mouse skeletal muscle. We initially chose this 
model because skeletal muscle is an abundant tissue 
that is also a rich source of mitochondria. As 
expected, muscle protein lysate from animals 
expressing the Cre recombinase under the control of 
the muscle creatine kinase (MCK) promoter 
demonstrated reduced Atg7 expression when 
compared to skeletal muscle tissue obtained from 
control mice (Figure 1A). Coincident with a 
reduction in Atg7 expression, we noted a marked 
increase in the level of p62, a protein cleared in large 
part through autophagy and whose levels are 
routinely used as a marker of overall autophagic flux 
[16]. Although these results suggest that autophagy 
in skeletal muscle was largely impaired in these 
conditionally ablated animals, when compared to 
control animals, we observed no obvious differences 
in terms of viability, overall size and activity, serum 
parameters or generalized appearance of the 
Atg7
F/F:MCK-Cre mice throughout the first year of 
life (unpublished observations). In addition, 
histological analysis revealed no discernable skeletal 
muscle structural abnormalities between knockout 
and control mice (Figure 1B). In contrast, electron 
micrographs demonstrated that Atg7
F/F:MCK-Cre 
mice accumulated markedly abnormal mitochondria 
that were especially evident in the sub-sarcolemma 
region of muscle fibers. These abnormal mitochon-
dria appeared less electron dense and were often 
swollen, lacking in cristae, or dysmorphic in 
appearance (Figure 1C). Despite these profound 
differences in mitochondrial appearance, we 
observed no obvious alterations in the composition 
of the various cytochrome complexes (Figure 1D), 
nor were there obvious differences in the assembly 
of individual electron transfer components using 
Blue Native Gel analysis (Figure 1E).  
 
In order to test whether the observed alterations in 
mitochondrial appearance were also accompanied by 
corresponding functional changes, we measured the 
basal and stimulated respiration of mitochondria 
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F/F:MCK-Cre and control animals. 
Preliminary experiments suggested that while 
Complex I dependent respiration was reduced, 
Complex II dependent respiration was even more 
impaired in Atg7 deficient muscle.  Using succinate 

















































be markedly reduced when we tested mitochondria 
isolated from Atg7 deficient animals (Figure 1F). 
These defects were evident under basal conditions 
(State IV) and even more so, under conditions of 
maximal stimulated respiration (State III) induced 














































































   










































-/- MEFs demonstrate impaired cellular 
respiration and increased ROS levels 
 
In order to further characterize the defect in 
mitochondrial function within the context of intact 
cells, we next isolated mouse embryonic fibroblasts 
(MEFs) from wild type or Atg7
-/- embryos (Figure 
2 A ) .  C o m p a r e d  t o  W T  M E F s ,  A t g 7
-/- MEFs 
exhibited a reduction in basal oxygen consumption 
(Figure 2B). In addition, we noted that Atg7
-/- MEFs 
demonstrated a marked reduction in maximal 




























































levels of FCCP-stimulated respiration. These 
differences were not a result of any apparent differ-
ences in overall mitochondrial numbers between the 
two cell types (Figure 2C). Coincident with this 
decrease in mitochondrial oxygen consumption, we 
noted that Atg7
-/- MEFs generated more lactic acid, 
consistent with an increase reliance on glycolysis 
(Figure 2D). This shift away from aerobic respiration 
and towards cytosolic glycolysis in Atg7
-/-  MEFs 
presumably represents a compensatory mechanism to 
maintain intracellular energetic homeostasis in the 
setting of dysfunctional mitochondria.  
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levels of reactive oxygen species (ROS). This 
increase in ROS can further increase mitochondrial 
damage leading in turn to more oxidant release and 
additional mitochondrial damage, in a process 
termed the ‘vicious cycle’[17]. In some circum-
stances, this perpetuating cycle of mitochondrial 
damage and oxidative stress is thought to contribute 
to normal aging as well as many age-related diseases 
[18]. Given the above observations, we next sought 
to assess whether continuous oxidative stress was 
evident in autophagy deficient cells. As noted in 
Figure 3A, Atg7
-/- MEFs had increased levels of 
intracellular ROS. Culturing these cells in the 
presence of the antioxidant N-acetylcysteine (NAC) 
resulted in a reduction in ROS levels (Figure 3B).  
 
Antioxidant treatment did not appear to alter the 
level of autophagic flux in Atg7
-/- MEFs as the level 
of p62 was unaltered in NAC treated cell (Figure 
4A). However, chronic NAC treatment did partially 
ameliorate the observed metabolic defect seen in 
these cells (Figure 4 B, C).  These results suggest 
that the continuous oxidative stress observed in 
Atg7
-/- MEFs contributes to the decline in mito-






























Oxidative stress and glucose intolerance in 
pancreatic Atg7
-/- mice   
 
Given the profound alterations observed in isolated 
mitochondria derived from Atg7 deficient skeletal 
muscle and the observation that NAC treatment 
could at least partially reverse the metabolic defects 
observed in Atg7
-/- MEFs, we next sought to assess 
whether these principles could be applied to the 
physiological defects seen in an in vivo model of 
Atg7 deficiency. Since our skeletal muscle 
conditional Atg7
-/- mice did not exhibit an overt 
phenotype, we created an additional model in which 
Atg7 was deleted within pancreatic β cells by 
crossing the Atg7-floxed mice with RIP2-Cre 
animals. Western blot analysis from purified 
pancreatic islets demonstrated that conditional 
knockout animals (Atg7
F/F:RIP2-Cre) had reduced or 
absent Atg7 expression and a corresponding increase 
in p62 levels (Figure 5A). In young mice, deletion of 
Atg7 within β cells did not result in significant 
alterations in pancreatic insulin expression (Figure 
5B). Similarly, the cellular composition of   
individual pancreatic islets was largely unperturbed 
in 8 week old mice (Figure 5 C, D). In contrast, 





































for  4  days  prior  to  imaging.  Values  represent  the  normalized  fluorescent  intensity  (arbitrary  units)  of  approximately  300  cells  per
condition. Graphs represent the mean +/‐ SEM. 
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abnormal mitochondria within the β cells of Atg7 
deficient mice (Figure 5E). Analysis of basal and 
FCCP-stimulated respiration from isolated pancre-
atic islets revealed a significant decrease in basal 
mitochondrial respiration and a marked decrease 
inmitochondrial oxidative capacity in Atg7 deficient 
islets (Figure 5F). Consistent with previous reports 
describing animals with alterations in β cell mito-
chondria [12, 13, 19], mice lacking Atg7 within their 
β cells also exhibited marked abnormalities in 
glucose tolerance (Figure 5G).  
 
We next asked what the role of continuous oxidative 
stress was in this model of β cell dysfunction. We 
randomized knockout or control mice beginning at 
age 4 weeks to treatment with or without NAC.  As 
expected, when compared to control animals, mice 
with conditional ablation of Atg7 accumulated 
increased levels of p62 within their islets (Figure 
6A). Treatment with NAC did not noticeably affect 
this accumulation in conditionally ablated animals 
(0/18 islets p62 positive in Atg7
F/+:RIP2-Cre mice; 
22/24 islets p62 positive in Atg7
F/F:RIP2-Cre mice 
and 17/17 islets p62 positive in Atg7
F/F: RIP2-Cre 
mice treated with NAC; in random slides obtained 
from n=3 mice per condition). In addition, as an in 
situ marker of oxidative stress, we measured 
nitrotyrosine levels which are known to increase and 
contribute to the diabetic phenotype [20] . As noted, 
levels of nitrotyrosine were markedly elevated in 
Atg7 deficient islets and in contrast to our 
observations with p62, treatment with NAC was 
very effective in reducing the observed increase 
(Figure 6 B, C).  
 
We next asked whether reducing the levels of 
oxidative stress by itself was sufficient to ameliorate 
the physiological impairment observed with 
conditional deletion of Atg7.  Littermates were 
randomized after weaning to treatment with or 
without NAC and subsequently assessed at age 16 
weeks. Consistent with continuous oxidative stress 
playing a causative role in the underlying 
physiology, and in contrast to untreated 
Atg7
F/F:RIP2-Cre mice,  NAC treated Atg7
F/F:RIP2-
Cre mice had a glucose tolerance response that was 
indistinguishable from control mice (Figure 7A). 
This protection was also seen at later time points, 
although the overall degree of rescue appeared to be 
reduced as the mice aged (data not shown). The 
observed differences in glucose homeostasis were 
not a result of reduced peripheral insulin sensitivity 
as insulin tolerance tests were comparable for all 
four groups tested (data not shown).  Furthermore, 
mice lacking Atg7 within their β cells develop a 
defect in glucose-stimulated insulin secretion, and 
this defect was not observed in conditionally ablated 

























































µM  NAC  for  10  days  prior  to  cellular  respiration  measurement.
Shown is a representative tracing of oxygen consumption performed
in  triplicate  under  basal  conditions,  following  the  addition  of
oligomycin (0.5 µM), the pharmacolo‐gical uncoupler FCCP (1 µM) or
the  Complex  III  inhibitor  antimycin  A  (0.25  µM).  (C)  Averaged
metabolic  profile  from  4  separate  experiments  employing  3
independent primary isolates of WT and Atg7
‐/‐ MEFs. Shown is the
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Using a variety of cellular and in vivo models, we 
demonstrate that impairment of autophagy leads to 
the accumulation of damaged and dysfunctional 
mitochondria and a corresponding increase in 
intracellular ROS levels. In a model of autophagy 
deficiency occurring within the pancreatic β cell, we 















































impairment in glucose tolerance and insulin 
secretion can be significantly ameliorated by the 
simple addition of an antioxidant. While assessment 
of autophagic flux by p62 expression suggests that 
NAC treatment does not directly affect autophagy, 
the ultimate improvement of glucose tolerance and 
glucose-stimulated insulin secretion suggests that at 
least for this in vivo model, continuous oxidative 



































































concentration  and  are  from  n=4  mice  per  genotype.  (G)  Impaired  glucose  tolerance  in  Atg7





   























































































F/+:Rip2‐Cre  (n=6  mice),  Atg7
F/+:Rip2‐Cre  (+NAC;  n=6
mice),  Atg7










F/+:Rip2‐Cre  (n=6  mice),  Atg7














  Figure  6.  In  vivo  treatment  with  NAC  reduces  oxidative
stress  within  pancreatic β  cells.  (A)  Atg7
F/+:Rip2‐Cre  or
Atg7
F/F:Rip2‐Cre  mice  that  were  untreated  or  treated  with  the
antioxidant NAC for 12 weeks.  At 16 weeks of age, mice were
sacrificed and serial sections of pancreatic tissue were analyzed
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stress may also play a role in the alterations in innate 
immunity observed in autophagy deficient cells [21]. 
In particular, ROS appeared to mediate the increase 
in interferon secretion and resistance to viral 
infection seen in Atg5
-/- cells. The form of 
autophagy studied in these experiments is quite 
specialized and involves the delivery of viral nucleic 
acids to the endosome rather than the standard 
situation where cargo is delivered to the lysosome. 
Similarly, it should be noted that in this context, 
Atg5 deficient cells demonstrate increased interferon 
protection and increased protection from viral 
infection rather than the usual situation where 
autophagy disruption results in a loss of function 
phenotype. Interestingly, in this recent study, Atg5
-/- 
MEFs exhibited an approximate 2-fold increase in 
the number of  mitochondrial genomes per cell, 
while for presently unclear reasons, we did not 
observe a similar increase in mitochondrial number 
in our Atg7
-/- MEFs (see Figure 2C).  
 
Based on these recent in vitro observations regarding 
Atg5 deletion in cells and our in vivo observations 
regarding Atg7 deletion in the pancreas, it is 
tempting to speculate that a rise in ROS levels may 
be a universal downstream mediator of the positive 
or negative alterations seen in autophagy deficient 
tissues. Nonetheless, other evidence suggests that 
such a broad conclusion is unlikely to be always 
correct. For instance, while the accumulation of 
ubiquitin positive protein aggregates in inclusion 
bodies are prominent features in Atg5 and Atg7 
deficient neurons and cardiomyocytes, these changes 
are not observed in T lymphocytes or dendritic cells 
that lack Atg5 expression [10; 11; 14; 22; 23]. This 
may reflect fundamental differences in the role of 
autophagy in rapidly dividing versus post-mitotic 
cells.  Similarly, even within a single tissue or organ, 
the effects of abrogating or inhibiting autophagy 
cannot always be easily predicted. For instance, 
deletion of Atg5 in adult mice leads to the 
spontaneous appearance of contractile dysfunction, 
while the same deletion performed early in cardio-
genesis does not result in any basal myocardial 
phenotype [14]. Even less straightforward are 
observations that while cardiac specific deletion of 
Atg5 results in an animal that is less able to 
withstand myocardial pressure overload, hetero-
zygous deletion of beclin, another essential 
autophagy gene, results in mice with the seemingly 
opposite cardiac phenotype [14; 24]. Thus, the 
downstream mediators and ultimate consequences of 
inhibiting autophagy may vary widely depending on 
the strategy used to disrupt autophagic flux and in 
what tissue or organ the disruption occurs.  
 
Our data suggests that antioxidant treatment with 
NAC is particularly beneficial in preventing the 
glucose intolerance phenotype observed following 
deletion of Atg7 within β cells. Pancreatic secretion 
of insulin is well known to be sensitive to changes in 
the cellular redox state and overall mitochondrial 
function. Given our results on the metabolic profile 
of Atg7
-/- MEFs cultured in the presence of NAC, it 
is tempting to think that in the setting of Atg7 
deletion, the in vivo use of antioxidants interrupts the 
‘vicious cycle’ of mitochondrial generated ROS 
inducing further mitochondrial damage. These 
observations suggest that antioxidant targeted 
therapy might be beneficial for at least a subset of 
the growing number of conditions where deficiency 




Mice and cells. Atg7
F/F mice have been previously 
described [9] and were crossed with either MCK-Cre 
mice (Jackson Laboratory) or RIP2-Cre mice 
(Jackson Laboratory) to generate mice with a 
conditional deletion of Atg7 within skeletal muscle 
or pancreatic β cells. For genotype analysis, 
 tissues 
were digested overnight
  at 55 °C with Gitschier 
buffer (67 mM Tris-HCL,
  pH 8.8, 16.6 mM 
ammonium sulfate, 6.5 mM MgCl2, 0.5% Triton
 X-
100, 1%  - mercaptoethanol, 100 µg/ml proteinase 
K). Samples were incubated at 95 °C for 5 min, 
shaken for 20 min with an Eppendorf thermomixer, 
and centrifuged at 16,100 x g for 2 min. Three 
primers 5’- TGGCTGCTACTTCTGCAA TGA TGT-
3’, 5’- GCAAGCTCACTAGGC TG CAGAACC-3’, 
and 5’-GGTCCA GAGTCCGGTCTC GG-3’ were 
used to detect the flox Atg7 allele in genomic DNA.  
 
Cre-mediated recombination was assessed by PCR 
analysis of genomic DNA using primers 5’- 
GGTCTGGCAG TAAAAACTATC-3’ and 5’-GTGA 
AACAGCATTGCTGTCACTT-3’, and 5’-GGGTCC 
CA AAGGCCGCC-3’ and 5’-GGATAGTTTTTACT 
GCCAGAC CGC-3’ for Rip2-CRE and  MCK-CRE, 
respectively [25; 26].  Similar to what has been 
recently described [12; 13], we observed no obvious 








F/+:RIP-Cre mice, and so we predominant-
ly present the latter two genotypes as representative 
controls in this study. 
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mice were treated with 1 g/L of NAC in the drinking 
water for the indicated duration of the study. All 
animal experiments were conducted in accordance 
with the guidelines of the Animal Care and Use 
Committee, National Heart Lung and Blood 
Institute, NIH.  
 
Mouse embryonic fibroblasts were prepared from 
E12-E14 day old embryos using standard methods. 
MEFs were prepared following a cross between 
Atg7
F/F mice with a transgenic mouse line carrying 
the Cre recombinase under the control of the 
adenoviral promoter EIIa that is known to be 
broadly expressed in the developing embryo [27].   
PCR analyses using primers, 5’- GCTG CTACTTC 
TGCAATGATGT-3’ and 5’GCAAGCTCACTAGG 
CTGCAGAACC-3’, were used to detect the wild-
type Atg7 gene and primers, 5’- GCTGCTAC   
TTCTGCAAT GATGT-3’ and 5’- ATG GTAC 
ATGCTAAGCCTCTGGAC-3’, were used to detect 
the deleted Atg7 gene.  MEFs were cultured in 
growth medium consisting of Dulbecco's Modified 
Eagle's medium (DMEM; Invitrogen) supplemented
 
with 15% fetal bovine serum (FBS), 50 units/ml 
penicillin and 50 µg/ml streptomycin.  For in vitro 
NAC treatment, freshly thawed primary MEFs at 
passage 2 were placed in growth medium 
supplemented with 500 µM NAC for 10 days with 
media being changed every other day.  
 
Glucose tolerance test, insulin measurement and islet 
isolation.  Overnight fasted male mice were given 
intraperitoneal injections of D-glucose (20% 
solution; 1 g/kg body weight) and blood glucose was 
determined using a one-touch Ascensia Elite 
glucometer (Fisher). Tail vein blood was collected at 
0 and 15 min following glucose injection and plasma 
insulin levels were measured with a rat insulin 
radioimmunoassay kit according to the manufac-
turer’s recommendations (Millipore). 
 
For pancreatic intracellular insulin measurement, 
small sections of pancreas were digested with 
ethanol/acid buffer (25 ml absolute ethanol, 8.3 ml 
ddH2O, and 0.5 ml concentrated HCl) overnight at 
4°C as previously described [30].  Insulin was 
measured with a Rat/Mouse Insulin ELISA Kit 
Insulin (Crystal Chem Inc.).  Tissue weight was used 
to normalize the intracellular insulin levels.  
 
Pancreatic islets were isolated using a standard 
protocol [31].  Briefly, the pancreas was perfused 
with a solution of 0.5 mg/ml Collagenase Type V 
(Sigma) dissolved in Hanks Balanced Salt Solution 
(HBSS) containing calcium and magnesium 
(Mediatech Inc).  The digestion was performed at 
37°C for 15-20 min after which the collagenase was 
neutralized with HBSS supplemented with 1% FBS. 
The collagenase treated pancreas was then 
sequentially filtered through 1.5 mm and 0.8 mm 
metal mesh filters.  Islets were subsequently 
enriched by centrifugation in Histopaque 1077 
(Sigma) and hand-picked under direct light 
microscopic visualization. 
 
Isolated mitochondrial and intact metabolic studies. 
Purified mitochondria were isolated from freshly 
harvested skeletal muscle using standard methods 
[28]. Briefly, isolated skeletal muscle were rapidly 
harvested, washed and minced in ice-cold Ionic 
Medium (100 mM surcrose, 10 mM EDTA, 100 mM 
Tris-HCL, 46 mM KCl, pH 7.4). The tissues were 
digested with 5% Proteinase Type XXIV (Sigma) in 
Ionic Medium for 5 min on ice and the protease was 
subsequently inactivated by the addition of Ionic 
Medium supplemented with 0.5% BSA.  Samples 
were then homogenized
  with a glass-Teflon 
motorized homogenizer and the mitochondrial 
fraction isolated by differential centrifugation. 
Mitochondria were subsequently washed twice and 
then resuspended in Suspension Medium (230 mM 
mannitol, 70 mM sucrose, 0.02 mM EDTA, 20 mM 
Tris-HCl, 5 mM K2HPO4, pH 7.4) prior to functional 
assessment.   Succinate (5 mM), rotenone (1 µM), 
Antimycin A (0.25 µM) and ADP (1 mM) were used 
to assay complex II dependent respiration.  
 
Measurement of intact cellular respiration was 
performed using the Seahorse XF24 analyzer 
(Seahorse Bioscience Inc.). Primary MEFs were 
plated at a density of 40,000 cells/well on XF24 
tissue culture plate.  Purified pancreatic islets were 
isolated and cultured overnight in DMEM 
supplemented with 10% FBS, 50 units/ml penicillin 
and 50 µg/ml streptomycin.  Two-three hours prior 
to respiration measurements, 50-100 islets were 
transferred to poly-L-lysine coated XF24 tissue 
culture plate.  Prior to the respiration assay, primary 
MEFs or islets were rinsed and cultured in DMEM 
running medium (8.3g/L DMEM (Sigma), 200 mM 
GlutaMax-1 (Invitrogen), 100mM sodium pyruvate 
(Sigma),  25 mM D-glucose (Sigma), 63.3 mM NaCl 
(Sigma), and phenol red (Sigma), adjust pH to 7.4 
with NaOH) according to manufacturer’s protocol.  
Oxygen consumption was measured under basal 
conditions, in the presence of the mitochondrial 
inhibitors oligomycin (0.5 µM) or antimycin A (0.25 
µM), or in the presence of the mitochondrial 
uncoupler FCCP (0.5 µM or 1 µM) to assess maxi-
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made by determining the change in extracellular pH 
over time, as previously described [29].  Oxygen 
consumption and lactate measurements were 
normalized to cell number for primary MEFs and 
protein concentration for pancreatic islets.  
 
Histology and Immunohistochemistry. Histological 
analysis was performed on 8-10 week old and 16-24 
week old mice. Skeletal muscle or pancreatic tissue 







F/+:RIP2-Cre , and Atg7
F/F:RIP2-Cre mice, 
respectively.   Tissues were fixed in 10% formalin 
and paraffin embedded tissue sections were used for 
subsequent hematoxylin and eosin (H&E) staining. 
Immunohistochemistry analysis with anti-insulin 
(DAKO), anti-glucagon (Sigma), anti-somatostatin 
(DAKO), and anti-polypeptide (Millipore) 
antibodies was performed using standard protocols. 
Cryostat sections were fixed with 4% paraformal-
dehyde in PBS prior to immunohistochemical 
analysis with either a nitrotyrosine antibody 
(Millipore) or p62 antibody (Progen Biotechnik).   
For quantification purposes, an islet was considered 
to stain positive for p62 or nitrotyrosine if greater 
than 5 cells within the islet exhibited positive 
staining. Rhodamine or Cy2 conjugated secondary 
antibodies (Jackson Immunological Research 
Laboratories) were used for visualization.  Electron 
micrographs were performed on ultrathin sections of 
tissues that were fixed in 2 or 2.5% glutaraldehye 
plus 1% paraformaldehyde, post-fixed with 1% 
OsO4, stained en bloc with 1% uranyl acetate and 
embedded in Embed 812 (Electron Microscopy 
Sciences) using standard methods.  The sections 
were stained with lead citrate and uranyl acetate 
before viewing.  
 
Western Blot Analysis. Primary MEFs or isolated 
pancreatic islets were lysed with Nonidet
 P-40 lysis 
buffer (1.0% Nonidet P-40, 50 mM Tris-HCl pH 7.4,
 
150 mM NaCl, 5 mM EDTA) supplemented with 
protease inhibitor tablet (Roche) and phosphatase 
inhibitors (1 mM Na3VO3, 1 mM β-glycerol-
phosphate, 10 mM NaF) for 15 min on ice prior to 
clarification
 by centrifugation at 16,100 x g for 15 
min at 4 °C.  Skeletal muscle was suspended in 
homogenizing buffer (25 mM Tris. HCl pH 7.4, 150 
mM NaCl, 5 mM EDTA, 1% Triton X-100, 0.1% 
SDS, 10% glycerol, 1 mM DTT, 0.5 % sodium 
deoxycholic acid) supplemented with protease and 
phosphatase inhibitors and homogenized using a 
tissue lyser (Qiagen). Protein concentration was 
determined with the Pierce BCA assay Kit (Thermo 
Fisher Scientific).  Protein lysates were resolved on 
precast Tris-Glycine SDS gels (Invitrogen) and 
transferred onto nitrocellulose. Immunoblot analysis 
was performed with antibodies directed against Atg7 
(ProSci Inc and Sigma), actin (Sigma), the Complex 
I component NDFS3 (NADH-ubiquinone oxido-
reductase, MitoSciences), the Complex II 
component FP (flavoprotein subunit of complex II, 
MitoSciences), and the Complex III component 
Core1 (Ubiquinol-cytochrome-c reductase complex 
core protein 1, MitoSciences). 
 
For detection of mitochondria complexes on native 
blue gels, purified mitochondria from skeletal 
muscle were resolved on Native PAGE Novex Bis-
Tris gels according to the manufacturer’s 
instructions (Invitrogen).  Briefly, 1 mg of a purified 
mitochondria pellet was resuspended with 100 µl of 
1x NativePAGE buffer and 12.5 µl of 10% 
maltoside (Sigma).  The samples were incubated on 
ice for 30 min with frequent vortexing before 
pelleting by centrifugation at 16,100 x g for 10 min 
at 4°C.  After centrifugation, 100 µl of supernatant 
was transferred to a new tube containing 6.3 µl of 
Coomassie blue additive and samples (approxi-
mately 50 µg) were then resolved by Native PAGE 
Novex Bis-Tris gel electrophoresis. 
 
ROS measurements. Primary MEFs were cultured 
on Nunc Lab-Tek two chamber glass slides.  As an 
internal control, each dual chamber slide contained 
one well of WT MEFs and one well of Atg7
-/- MEFs, 
or one well of Atg7
-/- MEFs and one well of Atg7
-/-  
MEFs that have been treated with 500 µM NAC for 
4 days.  Cells were incubated with HBSS containing 
50 µM 5-(and-6)-chloromethyl-2',7'-dichlorodi-
hydrofluorescein diacetate, acetyl ester (CM-
H2DCFDA; Invitrogen) for 30 min at 37°C.  Cells 
were then rinsed and mounted with mounting 
medium (Vector Labs) and visualized with a Leica 
SP1 confocal microscope as previously described 
[32].  Several random fields were taken of each 
genotype and mean fluorescence intensity was 
calculated in three or more separate experiments 
with data from over 250 cells using at least two 
independently isolated WT and Atg7
-/- MEF cell 
isolates. Attached cells were measured rather than 
MEF cell suspensions since we have previously 
observed dramatic alterations in ROS levels when 
attached cells are trypsinized [33]. 
 
Mitochondrial number. The ratio of mitochondrial 
DNA to nuclear DNA was determined as previously 
described [34]. In brief, quantitative PCR analysis 
using SYBR green (Applied Biosystems) was 
   
www.impactaging.com                  435                                     AGING, April 2009, Vol.1 No.4performed with 25 µg of isolated DNA (Qiagen).     
Mitochondrial DNA was assessed using primers, 5’-
CTCTTAT CCACGC TTCCGTTACG-3’ and 5’-
GATGGTGGTACTCCCGCT GTA-3’ for the mito-
chondrial-encoded ND1 gene.  Nuclear DNA level 
was determined by amplifying the genomic H19 
locus using primers 5’-GTACCCACCTGTCGTCC-
3’and 5’-GTCCACGAGACCAATGA CTG-3’.  The 
relative amount of mitochondrial to nuclear DNA 
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